Showing 13,881 - 13,900 results of 102,485 for search '(( 50 ((teer decrease) OR (mean decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 13881
  2. 13882
  3. 13883
  4. 13884
  5. 13885
  6. 13886
  7. 13887
  8. 13888
  9. 13889
  10. 13890
  11. 13891
  12. 13892
  13. 13893
  14. 13894
  15. 13895
  16. 13896
  17. 13897

    The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1<sup><i>st</i></sup> scenario, no lockdown is implemen... by Sara K. Al-Harbi (12418482)

    Published 2022
    “…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1<sup><i>st</i></sup> scenario, no lockdown is implemented; 2<sup><i>nd</i></sup> scenario, no lockdown while <i>SD</i> increases; 3<sup><i>rd</i></sup> scenario, lockdown increases; 4<sup><i>th</i></sup> scenario, <i>SD</i> increases; 5<sup><i>th</i></sup> scenario, lockdown decreases; 6<sup><i>th</i></sup> scenario, <i>SD</i> decreases; 7<sup><i>th</i></sup> scenario, lockdown and <i>SD</i> increases; 8<sup><i>th</i></sup> scenario, lockdown decreases and <i>SD</i> increases; 9<sup><i>th</i></sup> scenario, <i>ρ</i> is the same as in Phase 5; 10<sup><i>th</i></sup> scenario, <i>ρ</i> is the same as in Phase 5 while <i>SD</i> increases.…”
  18. 13898

    Supplementary Material for: Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy by Girard A. (4154179)

    Published 2015
    “…First-line treatments were endothelin receptor antagonists in 11 patients, phosphodiesterase-5 inhibitors in 11 patients, calcium blocker in 1 patient, combination therapy in 3 patients including 2 with a prostanoid. …”
  19. 13899

    Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> receptors for Parkinson's disease treatment - Fig 5 by Yi-Ming Shao (577266)

    Published 2018
    “…<p>Dose-response curves of compound <b>5</b> (A), compound <b>6</b> (B) and (±)-PPHT.HCl (C) in D<sub>2</sub>R-proteopolymersomes-based fluorescence polarisation (FP) competition assay with BODIPY-NAPS. …”
  20. 13900

    Table1_Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.xlsx by Bo Liang (450389)

    Published 2022
    “…<p>The Chanarin–Dorfman syndrome (CDS) is a rare, autosomal recessively inherited genetic disease, whch is associated with a decrease in the lipolysis activity in multiple tissue cells. …”